477 IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replication.
http://www.pnas.org/content/110/48/E4571.abstract
476 HIV-1 evades innate immune recognition through specific cofactor recruitment.
http://www.nature.com/nature/journal/v503/n7476/full/nature12769.html
475 Staphylococcus δ-toxin induces allergic skin disease by activating mast cells.
http://www.nature.com/nature/journal/v503/n7476/full/nature12655.html
474 Activated ClpP kills persisters and eradicates a chronic biofilm infection.
http://www.nature.com/nature/journal/v503/n7476/full/nature12790.html
473 A genetic strategy to identify targets for the development of drugs that prevent bacterial persistence.
http://www.pnas.org/content/110/47/19095.abstract
472 MCPIP1 restricts HIV infection and is rapidly degraded in activated CD4+ T cells.
http://www.pnas.org/content/110/47/19083.abstract
471 Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X
http://www.pnas.org/content/110/47/19077.abstract
470 A Ca2+-dependent signalling circuit regulates influenza A virus internalization and infection.
http://www.nature.com/ncomms/2013/131114/ncomms3763/full/ncomms3763.html
469 Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia.
http://www.nature.com/nature/journal/v503/n7475/full/nature12746.html
468 Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys.
http://www.nature.com/nature/journal/v503/n7475/full/nature12744.html
|